US 12,102,564 B2
Ophthalmic therapeutic device and control method therefor
Bong Kyun Kim, Cheonan-si (KR); Sun Jeong Ham, Seoul (KR); and Gi Hoon Kim, Seoul (KR)
Assigned to LUTRONIC CORPORATION, Goyang-si (KR)
Appl. No. 17/416,264
Filed by LUTRONIC CORPORATION, Goyang-si (KR)
PCT Filed Dec. 9, 2019, PCT No. PCT/KR2019/017316
§ 371(c)(1), (2) Date Jun. 18, 2021,
PCT Pub. No. WO2020/130449, PCT Pub. Date Jun. 25, 2020.
Claims priority of application No. 10-2018-0163732 (KR), filed on Dec. 18, 2018.
Prior Publication US 2022/0054307 A1, Feb. 24, 2022
Int. Cl. A61F 9/008 (2006.01); G16H 20/40 (2018.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01)
CPC A61F 9/008 (2013.01) [G16H 20/40 (2018.01); A61B 2017/00115 (2013.01); A61B 2018/00702 (2013.01); A61F 9/00821 (2013.01); A61F 2009/00851 (2013.01); A61F 2009/00863 (2013.01)] 19 Claims
OG exemplary drawing
 
1. An ophthalmic treatment apparatus comprising:
a display unit for displaying an image of a patient's eyeground;
a treatment region setting unit for setting a treatment region on the basis of the image of the patient's eyeground;
a treatment beam radiating unit for radiating a treatment beam to the set treatment region;
a radiation density setting unit for setting radiation density of the treatment beam radiated to the set treatment region; and
a control unit for controlling the treatment beam radiating unit so as to radiate the treatment beam onto the set treatment region on the basis of the set density,
wherein the display unit displays an eyeground sample chart in which main organs of the eyeground are schematically displayed, and the treatment region setting unit sets the treatment region on the eyeground sample chart.